2 results
Approved WMOCompleted
Primary: progression-free survival in the GSK1120212-group in comparison with the docetaxel group. Secondary: safety and tolerability, response rate, duration of response, overall survival, PK.
Approved WMOCompleted
Main objective of the study is to shift rhythms in late chronotypes and thereby lengthen sleep on workdays and align endogenous rhythms